Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 143

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 143
---
 adverse effect on our financial condition and results of operations. There can be no assurance that the Company’s securities that will be issued in connection with the Business Combination will be approved for listing on the Nasdaq or, if approved, will continue to be so listed following the closing of the Business Combination, or that the Company will be able to comply with the continued listing standards of Nasdaq. We intend to apply for the listing of the Company Shares and Company Warrants on Nasdaq. If Nasdaq denies our application for failure to meet the listing standards or if we subsequently do not satisfy any additional listing standards, we and our shareholders could face significant material adverse consequences including: •a limited availability of market quotations for our securities; •reduced liquidity for our securities; •a determination that the Company Shares are a “penny stock” which will require brokers trading in the Company Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for its securities; •a limited amount of news and analyst coverage; and •a decreased ability to issue additional securities or obtain additional financing in the future. The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” If the Company Shares are listed on Nasdaq, they will be covered securities; however, if the Company Shares cease to be listed, our securities will not be covered securities and we would be subject to regulation in each state in which we offer our securities. Certain recent public offerings of companies with public floats comparable to the Company public float have experienced extreme volatility that was seemingly unrelated to the underlying performance of the respective company. The Company may experience similar volatility, which may make it difficult for prospective investors to assess the value of the Company Shares. The Company Shares may be subject to extreme volatility that is seemingly unrelated to the underlying performance of our business. Recently, companies with comparable public floats and initial public offering sizes have experienced instances of extreme stock price run -upsfollowed by rapid price declines, and such stock price volatility 51 was seemingly unrelated to the respective company’s underlying performance. Although the specific cause of such volatility is unclear, our public float may amplify the impact of the actions taken by a few shareholders on the price of Company Shares, which may cause our share price to deviate, potentially significantly, from a price that better reflects the underlying performance of our business. Should the Company Shares experience run -upsand declines that